Lv21
194 积分 2024-03-04 加入
Umeclidinium for the treatment of chronic obstructive pulmonary disease
5小时前
已完结
Umeclidinium for the treatment of chronic obstructive pulmonary disease
5小时前
已关闭
Umeclidinium for the treatment of chronic obstructive pulmonary disease
5小时前
已关闭
The Role of Long-Acting Antimuscarinic Agents in the Treatment of Asthma
6小时前
已完结
Red Book: 2024–2027 Report of the Committee on Infectious Diseases
3天前
求助中
Pharmacokinetics, Mass Balance, Tissue Distribution and Metabolism of [14C]101BHG-D01, a Novel Muscarinic Receptor Antagonist, in Rats
7天前
已完结
Nefopam enantiomers: Preclinical pharmacology/toxicology and pharmacokinetic characteristics in healthy subjects after intravenous administration
7天前
已完结
Safety, Tolerability, and Pharmacokinetic Study of 101BHG-D01 Nasal Spray, a Novel Long-Acting and Selective Cholinergic M Receptor Antagonist, in Healthy Chinese Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation, First-In-Human Study
10天前
已完结
The Role of Neuro-Immune Interactions in the Pathology and Pathogenesis of Allergic Rhinitis
10天前
已完结
Effects of 101BHG-D01, a novel M receptor antagonism, on allergic rhinitis in animal models and its mechanism
10天前
已完结
皖公网安备34019202002308
